GlassScriptPhysician profile
Diana L Lackey
NPI 1942341615
$1,168.37
in general payments reported to CMS, 2019-2025
9 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $155 · 2023: $246 · 2024: $538 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,013.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $425.77 | 2023-2025 | Fetroja |
| Janssen Pharmaceuticals, INC | $225.18 | 2022-2024 | Xarelto |
| Pfizer INC. | $123.90 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $110.78 | 2023-2025 | Xifaxan |
| Ucb, INC. | $108.86 | 2023-2024 | Briviact |
| Merck Sharp & Dohme LLC | $108.76 | 2024-2025 | Zerbaxa, Recarbrio, Dificid |
| Novo Nordisk INC | $23.11 | 2024 | Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $21.01 | 2025 | Camzyos |
| Abbvie INC. | $21.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Lackey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.